PART 01: EXECUTIVE SUMMARY PART 02: SCOPE OF THE REPORT • 2.1 Preface • 2.2 Preface • 2.3 Currency conversion rates for US$ PART 03: MARKET LANDSCAPE • Market ecosystem • Market characteristics • Market segmentation analysis PART 04: MARKET SIZING • Market definition • Market sizing 2018 • Market size and forecast 2018-2023 PART 05: FIVE FORCES ANALYSIS • Bargaining power of buyers • Bargaining power of suppliers • Threat of new entrants • Threat of substitutes • Threat of rivalry • Market condition PART 06: MARKET SEGMENTATION BY TYPE • Market segmentation by type • Comparison by type • Hormonal intrauterine device - Market size and forecast 2018-2023 • Copper intrauterine device - Market size and forecast 2018-2023 • Market opportunity by type PART 07: CUSTOMER LANDSCAPE PART 08: MARKET SEGMENTATION BY END-USER • Market segmentation by end-user • Comparison by end-user • Hospitals - Market size and forecast 2018-2023 • Gynecology clinics - Market size and forecast 2018-2023 • Others - Market size and forecast 2018-2023 • Market opportunity by end-user PART 09: GEOGRAPHIC LANDSCAPE • Geographic segmentation • Geographic comparison • Europe - Market size and forecast 2018-2023 • North America - Market size and forecast 2018-2023 • Asia - Market size and forecast 2018-2023 • ROW - Market size and forecast 2018-2023 • Key leading countries • Market opportunity PART 10: DECISION FRAMEWORK PART 11: DRIVERS AND CHALLENGES • Market drivers • Market challenges PART 12: MARKET TRENDS PART 13: VENDOR LANDSCAPE • Overview • Landscape disruption PART 14: VENDOR ANALYSIS • Vendors covered • Vendor classification • Market positioning of vendors • ALLERGAN • Bayer • EUROGINE • Mylan • Pregna • The Cooper Companies PART 15: APPENDIX • Research methodology • List of abbreviations PART 16: EXPLORE TECHNAVIO   Exhibit 01: Global medical devices market Exhibit 02: Segments of global medical devices market Exhibit 03: Market characteristics Exhibit 04: Market segments Exhibit 05: Market definition - Inclusions and exclusions checklist Exhibit 06: Market size 2018 Exhibit 07: Global market: Size and forecast 2018-2023 ($ millions) Exhibit 08: Global market: Year-over-year growth 2019-2023 (%) Exhibit 09: Five forces analysis 2018 Exhibit 10: Five forces analysis 2023 Exhibit 11: Bargaining power of buyers Exhibit 12: Bargaining power of suppliers Exhibit 13: Threat of new entrants Exhibit 14: Threat of substitutes Exhibit 15: Threat of rivalry Exhibit 16: Market condition - Five forces 2018 Exhibit 17: Type - Market share 2018-2023 (%) Exhibit 18: Comparison by type Exhibit 19: Hormonal intrauterine device - Market size and forecast 2018-2023 ($ millions) Exhibit 20: Hormonal intrauterine device - Year-over-year growth 2019-2023 (%) Exhibit 21: Copper intrauterine device - Market size and forecast 2018-2023 ($ millions) Exhibit 22: Copper intrauterine device - Year-over-year growth 2019-2023 (%) Exhibit 23: Market opportunity by type Exhibit 24: Customer landscape Exhibit 25: End-user - Market share 2018-2023 (%) Exhibit 26: Comparison by end-user Exhibit 27: Hospitals - Market size and forecast 2018-2023 ($ millions) Exhibit 28: Hospitals - Year-over-year growth 2019-2023 (%) Exhibit 29: Gynecology clinics - Market size and forecast 2018-2023 ($ millions) Exhibit 30: Gynecology clinics - Year-over-year growth 2019-2023 (%) Exhibit 31: Others - Market size and forecast 2018-2023 ($ millions) Exhibit 32: Others - Year-over-year growth 2019-2023 (%) Exhibit 33: Market opportunity by end-user Exhibit 34: Market share by geography 2018-2023 (%) Exhibit 35: Geographic comparison Exhibit 36: Europe - Market size and forecast 2018-2023 ($ millions) Exhibit 37: Europe - Year-over-year growth 2019-2023 (%) Exhibit 38: North America - Market size and forecast 2018-2023 ($ millions) Exhibit 39: North America - Year-over-year growth 2019-2023 (%) Exhibit 40: Asia - Market size and forecast 2018-2023 ($ millions) Exhibit 41: Asia - Year-over-year growth 2019-2023 (%) Exhibit 42: ROW - Market size and forecast 2018-2023 ($ millions) Exhibit 43: ROW - Year-over-year growth 2019-2023 (%) Exhibit 44: Key leading countries Exhibit 45: Market opportunity Exhibit 46: Impact of drivers and challenges Exhibit 47: IUD types Exhibit 48: Vendor landscape Exhibit 49: Landscape disruption Exhibit 50: Vendors covered Exhibit 51: Vendor classification Exhibit 52: Market positioning of vendors Exhibit 53: ALLERGAN - Vendor overview Exhibit 54: ALLERGAN - Business segments Exhibit 55: ALLERGAN - Organizational developments Exhibit 56: ALLERGAN - Segment focus Exhibit 57: ALLERGAN - Key offerings 0 Exhibit 58: Bayer - Vendor overview 1 Exhibit 59: Bayer - Product segments 1 Exhibit 60: Bayer - Organizational developments 2 Exhibit 61: Bayer - Geographic focus 3 Exhibit 62: Bayer - Segment focus 3 Exhibit 63: Bayer - Key offerings 3 Exhibit 64: EUROGINE - Vendor overview 5 Exhibit 65: EUROGINE - Key offerings 5 Exhibit 66: Mylan - Vendor overview 7 Exhibit 67: Mylan - Business segments 7 Exhibit 68: Mylan - Organizational developments 8 Exhibit 69: Mylan - Segment focus 8 Exhibit 70: Mylan - Key offerings Exhibit 71: Pregna - Vendor overview Exhibit 72: Pregna - Key offerings Exhibit 73: The Cooper Companies - Vendor overview Exhibit 74: The Cooper Companies - Business segments Exhibit 75: The Cooper Companies - Organizational developments Exhibit 76: The Cooper Companies - Geographic focus Exhibit 77: The Cooper Companies - Segment focus Exhibit 78: The Cooper Companies - Key offerings  

ALLERGAN Bayer EUROGINE Mylan Pregna and The Cooper Companies